A. Vigani

发表

Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.

G. Bertelli, P. Pronzato, M. Vanoli, 1995, Anticancer research.

Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment.

M. Pistillo, S. Roncella, Ilan Rosenberg, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Anthacyclines in non-small cell lung cancer

P. Pronzato, A. Tognoni, A. Vigani, 2001 .

Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis

M. Pistillo, S. Roncella, A. Poggi, 2020, Journal of Cancer Research and Clinical Oncology.

A phase II trial of carboplatin, methotrexate and fluorouracil in fluorouracil-pretreated colorectal cancer.

P. Pronzato, A. Tognoni, F. Botto, 1998, Journal of chemotherapy.

Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.

G. Bertelli, P. Pronzato, A. Vigani, 1994, Anticancer research.

A Three-Drug Regimen (Gemcitabine, Ifosfamide and Cisplatin) for Advanced Non-Small-Cell Lung Cancer

P. Pronzato, A. Tognoni, A. Vigani, 2001, Journal of chemotherapy.

A phase II study of a three-drug combination (cisplatin, ifosfamide and vinorelbine) plus granulocyte-colony stimulating factor in advanced non small cell lung cancer.

P. Pronzato, A. Tognoni, A. Vigani, 1999, Journal of chemotherapy.

A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.

G. Bertelli, P. Pronzato, A. Vigani, 1996, British Journal of Cancer.

Carboplatin and vinorelbine in advanced non-small-cell lung cancer

P. Pronzato, A. Vigani, F. Vaira, 1996, Cancer Chemotherapy and Pharmacology.

Second line chemotherapy with ifosfamide as outpatient treatment for advanced bladder cancer.

P. Pronzato, M. Vanoli, A. Vigani, 1997, American journal of clinical oncology.

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer

P. Conte, R. Rosso, P. Pronzato, 2005, Breast Cancer Research and Treatment.

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

S. Zupo, M. Dono, M. Ferrarini, 2019, Molecular medicine.

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

D. Beer, D. Merlo, S. Roncella, 2017, Oncotarget.

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma

Federica, Paola, D. Beer, 2017, Oncotarget.

Randomized cooperative study of perioperative chemotherapy in breast cancer.

P. Bruzzi, P. Queirolo, G. Bertelli, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

P. Queirolo, P. Pronzato, F. Cafiero, 2004, Breast Cancer Research and Treatment.

A dose finding study for the combination of epidoxorubicin and vinorelbine, delivered every two weeks with G-CSF support, in advanced breast cancer.

P. Pronzato, A. Tognoni, A. Vigani, 1998, Journal of chemotherapy.

Adult pulmonary blastoma: Report of an unusual malignant lung tumor.

L. D'Ambra, E. Francone, A. Vigani, 2014, World journal of clinical oncology.

Effect of recombinant human tumor necrosis factor on A2774 human ovarian cancer cell line: potentiation of mitoxantrone cytotoxicity.

S. Parodi, P. Russo, P. Conte, 1991, Gynecologic oncology.

Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma

M. Pistillo, S. Roncella, V. Fontana, 2019, AntiCancer Research.

Phase II study of vinorelbine and ifosfamide in anthracycline resistant metastatic breast cancer.

P. Queirolo, P. Pronzato, F. Cafiero, 1997, Breast cancer research and treatment.

Mitoxantrone and 5-fluorouracil modulated by the pure (6S) stereoisomer of leucovorin as second-line chemotherapy for advanced breast cancer.

G. Bertelli, P. Pronzato, A. Vigani, 1994, European journal of cancer.

CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor

M. Pistillo, M. Ceppi, D. Merlo, 2016, Cancer Immunology, Immunotherapy.

Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients

S. Zupo, M. Dono, M. Ferrarini, 2019, Molecular Medicine.

Pilot Study to Evaluate Serum Soluble Mesothelin-Related Peptide (SMRP) as Marker for Clinical Monitoring of Pleural Mesothelioma (PM): Correlation with Modified RECIST Score

M. Pistillo, F. Grosso, S. Roncella, 2021, Diagnostics.

Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma

A. Ardizzoni, R. Rosso, C. Frola, 1997, Cancer.

Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility study.

P. Russo, O. Garrone, P. Conte, 1995, Anticancer research.